{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-024979","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2025-08-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.761128+00:00","generated_at":"2026-05-17T11:10:17.215054+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vivos Therapeutics reports Q2 2025 revenue $3.8M, operating loss $4.9M; acquired Sleep Center of Nevada","bullets":["Q2 2025 revenue $3.8M vs $4.1M YoY; gross margin fell to 55% from 65%.","Operating loss widened to $4.9M from $1.9M; expenses up 52% on acquisition-related costs.","Cash at June 30, 2025 was $4.4M, down from $6.2M at December 31, 2024.","Acquired Sleep Center of Nevada on June 10; generated ~$500k diagnostic revenue in 20 days with demand exceeding capacity.","Entered management agreement with MISleep Solutions for Michigan center; opening expected October 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-024979","json":"https://secwatch.observer/filing/0001641172-25-024979.json","markdown":"https://secwatch.observer/filing/0001641172-25-024979.md","text":"https://secwatch.observer/filing/0001641172-25-024979.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000164117225024979/0001641172-25-024979-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000164117225024979/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:10:17.215054+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}